Skip to main content

Megan Justine Huchko

Hollier Family Associate Professor of Global Health
Obstetrics and Gynecology, Women's Community & Population Health
Box 90519, Durham, NC 27708
310 Trent Drive, Room 204, Durham, NC 27708

Overview


Megan Huchko, MD, MPH, holds a dual appointment as an Associate Professor in the Department of Obstetrics & Gynecology and the Duke Global Health Institute.  Dr. Huchko was an undergraduate at Duke before moving to New York City to complete medical school at the Albert Einstein College of Medicine, and residency training at Columbia Presbyterian Medical Center.  She completed her fellowship in Reproductive Infectious Disease the University of California, San Francisco, and was a faculty member there. 

Dr. Huchko practices as an ob/gyn generalist and specializes in cervical cancer prevention through her clinical work and global women’s health research.  Her research focuses on optimizing the diagnosis and treatment of cervical cancer among vulnerable women in settings where health disparities occur. She has been working with the Family AIDS Care and Education Services (FACES) program in the Nyanza Province of western Kenya since 2006.  

She designed and implemented a cervical cancer screening and prevention (CCSP) program for HIV-infected women enrolled in care at FACES.  The CCSP program has provided a clinical resource, as well as a cohort to evaluate the epidemiology of cervical cancer among HIV-infected women, the feasibility of integrating cervical cancer prevention programs into HIV and general outpatient clinics, the safety of various diagnostic and treatment modalities, the efficacy of low-cost/low-resource screening modalities in HIV-infected women and provider and patient-level barriers and facilitators to uptake of cervical cancer prevention activities.  

Currently, she is carrying out several large studies in central Uganda and western Kenya to evaluate the optimal implementation strategy for HPV-based cervical cancer screening in rural settings.  At Duke, she leads the Center of Excellence in Global Women’s Health through the Global Health Institute and serves as Director for the Ob/Gyn Clinical Research Unit (CRU).

Current Appointments & Affiliations


Hollier Family Associate Professor of Global Health · 2021 - Present Obstetrics and Gynecology, Women's Community & Population Health, Obstetrics and Gynecology
Associate Professor of Obstetrics and Gynecology · 2022 - Present Obstetrics and Gynecology, Women's Community & Population Health, Obstetrics and Gynecology
Associate Research Professor of Global Health · 2016 - Present Duke Global Health Institute, University Institutes and Centers
Member of the Duke Cancer Institute · 2017 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published October 10, 2024
The Promise of Self-Testing to Prevent Cervical Cancer
Published July 31, 2024
To Help Mothers Access Health Care, Duke Students Launch Childcare Center in Kenya
Published November 30, 2023
Saving Women, Girls from a Preventable Cancer

View All News

Recent Publications


Automated Image Clarity Detection for the Improvement of Colposcopy Imaging with Multiple Devices.

Journal Article Biomed Signal Process Control · February 2025 UNLABELLED: The proportion of women dying from cervical cancer in middle- and low-income countries is over 60%, twice that of their high-income counterparts. A primary screening strategy to eliminate this burden is cervix visualization and application of 3 ... Full text Link to item Cite

Updated Review for Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.

Journal Article J Low Genit Tract Dis · January 13, 2025 OBJECTIVE: The purpose of this review was to examine new evidence since our 2019 guidelines for cervical cancer (CC) screening in non-HIV immunocompromised persons and to provide updated recommendations based on literature review and expert opinion. In add ... Full text Link to item Cite

Primary HPV screening compared with other cervical cancer screening strategies in women with HIV: a cost-effectiveness study.

Journal Article AIDS · December 1, 2024 OBJECTIVE: To compare the model-predicted benefits, harms, and cost-effectiveness of cytology, cotesting, and primary HPV screening in US women with HIV (WWH). DESIGN: We adapted a previously published Markov decision model to simulate a cohort of US WWH. ... Full text Link to item Cite
View All Publications

Recent Grants


mSaada: a mobile application to strengthen community-based cervical cancer screening

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2027

Technology-enabled Single-Visit Model for Cervical Cancer Prevention at the Community Level

ResearchCo-Principal Investigator · Awarded by National Cancer Institute · 2022 - 2027

Developing a Stigma-Responsive Intervention to Offer Cervical Cancer Prevention Services in HIV Care Facilities

ResearchPrincipal Investigator · Awarded by Fogarty International Center · 2022 - 2025

View All Grants

Education, Training & Certifications


University of California, Berkeley · 2007 M.P.H.
Yeshiva University, Albert Einstein College of Medicine · 2002 M.D.
Duke University · 1997 B.A.